Works by Peipp, Matthias

Results: 54

FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils.

Published in:

Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2018.03124

By:

Treffers, Louise W.;
van Houdt, Michel;
Bruggeman, Christine W.;
Heineke, Marieke H.;
Zhao, Xi Wen;
van der Heijden, Joris;
Nagelkerke, Sietse Q.;
Verkuijlen, Paul J. J. H.;
Geissler, Judy;
Lissenberg-Thunnissen, Suzanne;
Valerius, Thomas;
Peipp, Matthias;
Franke, Katka;
van Bruggen, Robin;
Kuijpers, Taco W.;
van Egmond, Marjolein;
Vidarsson, Gestur;
Matlung, Hanke L.;
van den Berg, Timo K.

Publication type:

Article

Tribody [(HER2)<sub>2</sub>xcD16] is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells.

Published in:

Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00814

By:

Oberg, Hans H.;
Kellner, Christian;
Gonnermann, Daniel;
Sebens, Susanne;
Bauerschlag, Dirk;
Gramatzki, Martin;
Kabelitz, Dieter;
Peipp, Matthias;
Wesch, Daniela

Publication type:

Article

Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma.

Published in:

Cancers, 2021, v. 13, n. 12, p. 3072, doi. 10.3390/cancers13123072

By:

Lejeune, Margaux;
Duray, Elodie;
Peipp, Matthias;
Clémenceau, Béatrice;
Baron, Frédéric;
Beguin, Yves;
Caers, Jo

Publication type:

Article

NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats.

Published in:

Protein Science: A Publication of the Protein Society, 2023, v. 32, n. 3, p. 1, doi. 10.1002/pro.4593

By:

Lipinski, Britta;
Arras, Paul;
Pekar, Lukas;
Klewinghaus, Daniel;
Boje, Ammelie Svea;
Krah, Simon;
Zimmermann, Jasmin;
Klausz, Katja;
Peipp, Matthias;
Siegmund, Vanessa;
Evers, Andreas;
Zielonka, Stefan

Publication type:

Article

Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen.

Published in:

Biological Chemistry, 2022, v. 403, n. 5/6, p. 545, doi. 10.1515/hsz-2021-0229

By:

Kellner, Christian;
Lutz, Sebastian;
Oberg, Hans-Heinrich;
Wesch, Daniela;
Otte, Anna;
Diemer, Katarina J.;
Wilcken, Hauke;
Bauerschlag, Dirk;
Glüer, Claus-Christian;
Wichmann, Christian;
Kabelitz, Dieter;
Leusen, Jeanette H. W.;
Klausz, Katja;
Humpe, Andreas;
Gramatzki, Martin;
Peipp, Matthias

Publication type:

Article

Editorial: Effector functions of therapeutic antibodies.

Published in:

Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1126966

By:

Boross, Peter;
Peipp, Matthias;
Nimmerjahn, Falk

Publication type:

Article

Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.957874

By:

Gehlert, Carina Lynn;
Rahmati, Pegah;
Boje, Ammelie Svea;
Winterberg, Dorothee;
Krohn, Steffen;
Theocharis, Thomas;
Cappuzzello, Elisa;
Lux, Anja;
Nimmerjahn, Falk;
Ludwig, Ralf J.;
Lustig, Marta;
Rösner, Thies;
Valerius, Thomas;
Schewe, Denis Martin;
Kellner, Christian;
Klausz, Katja;
Peipp, Matthias

Publication type:

Article

The relevance of complement in pemphigoid diseases: A critical appraisal.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.973702

By:

Papara, Cristian;
Karsten, Christian M.;
Hideyuki Ujiie;
Schmidt, Enno;
Schmidt-Jime´ nez, Leon F.;
Baican, Adrian;
Freire, Patricia C.;
Izumi, Kentaro;
Bieber, Katja;
Peipp, Matthias;
Verschoor, Admar;
Ludwig, Ralf J.;
Köhl, Jörg;
Zillikens, Detlef;
Hammers, Christoph M.

Publication type:

Article

Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.949140

By:

Baumann, Niklas;
Arndt, Christian;
Petersen, Judith;
Lustig, Marta;
Rösner, Thies;
Klausz, Katja;
Kellner, Christian;
Bultmann, Miriam;
Bastian, Lorenz;
Vogiatzi, Fotini;
Leusen, Jeanette H. W.;
Burger, Renate;
Schewe, Denis M.;
Peipp, Matthias;
Valerius, Thomas

Publication type:

Article

Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.908093

By:

Krohn, Steffen;
Boje, Ammelie Svea;
Gehlert, Carina Lynn;
Lutz, Sebastian;
Darzentas, Nikos;
Knecht, Henrik;
Herrmann, Dietrich;
Brüggemann, Monika;
Scheidig, Axel J.;
Weisel, Katja;
Gramatzki, Martin;
Peipp, Matthias;
Klausz, Katja

Publication type:

Article

Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.

Published in:

Neuro-Oncology, 2023, v. 25, n. 11, p. 2001, doi. 10.1093/neuonc/noad108

By:

Hänsch, Lena;
Peipp, Matthias;
Mastall, Maximilian;
Villars, Danielle;
Myburgh, Renier;
Silginer, Manuela;
Weiss, Tobias;
Gramatzki, Dorothee;
Vasella, Flavio;
Manz, Markus G;
Weller, Michael;
Roth, Patrick

Publication type:

Article

Ig A EGFR antibodies mediate tumour killing in vivo.

Published in:

EMBO Molecular Medicine, 2013, v. 5, n. 8, p. 1213, doi. 10.1002/emmm.201201929

By:

Boross, Peter;
Lohse, Stefan;
Nederend, Maaike;
Jansen, Johannes Hendrik Marco;
van Tetering, Geert;
Dechant, Michael;
Peipp, Matthias;
Royle, Louise;
Liew, Li Phing;
Boon, Louis;
van Rooijen, Nico;
Bleeker, Wim K.;
Parren, Paul W. H. I.;
van de Winkel, Jan G. J.;
Valerius, Thomas;
Leusen, Jeanette H. W.

Publication type:

Article

Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy.

Published in:

Transfusion Medicine & Hemotherapy, 2017, v. 44, n. 5, p. 327, doi. 10.1159/000479980

By:

Kellner, Christian;
Otte, Anna;
Cappuzzello, Elisa;
Klausz, Katja;
Peipp, Matthias

Publication type:

Article

An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated Cytotoxicity.

Published in:

Transfusion Medicine & Hemotherapy, 2017, v. 44, n. 5, p. 292, doi. 10.1159/000479978

By:

Wirt, Tim;
Rosskopf, Sophia;
Rösner, Thies;
Eichholz, Klara Marie;
Kahrs, Anne;
Lutz, Sebastian;
Kretschmer, Anna;
Valerius, Thomas;
Klausz, Katja;
Otte, Anna;
Gramatzki, Martin;
Peipp, Matthias;
Kellner, Christian

Publication type:

Article

Antibody Engineering – Tailor-Made Next Generation Antibodies by Molecular Design.

Published in:

Transfusion Medicine & Hemotherapy, 2017, v. 44, n. 5, p. 290, doi. 10.1159/000479617

By:

Humpe, Andreas;
Peipp, Matthias

Publication type:

Article

ADAM17-overexpressing breast cancer cells selectively targeted by antibody-toxin conjugates.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 3, p. 411, doi. 10.1007/s00262-012-1346-x

By:

Trad, Ahmad;
Hansen, Hinrich;
Shomali, Mohammad;
Peipp, Matthias;
Klausz, Katja;
Hedemann, Nina;
Yamamoto, Kosuke;
Mauermann, André;
Desel, Christine;
Lorenzen, Inken;
Lemke, Hilmar;
Rose-John, Stefan;
Grötzinger, Joachim

Publication type:

Article

Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 233, doi. 10.1007/s00262-007-0370-8

By:

Stieglmaier, Julia;
Bremer, Edwin;
Kellner, Christian;
Liebig, Tanja M.;
ten Cate, Bram;
Peipp, Matthias;
Schulze-Koops, Hendrik;
Pfeiffer, Matthias;
Bühring, Hans-Jörg;
Greil, Johann;
Oduncu, Fuat;
Emmerich, Bertold;
Fey, Georg H.;
Helfrich, Wijnand

Publication type:

Article

Prosaposin hyperglycosylation: a novel tumor immune escape mechanism and implications for cancer immunotherapy.

Published in:

Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01877-2

By:

Peipp, Matthias;
Dudziak, Diana;
Kellner, Christian

Publication type:

Article

Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies.

Published in:

Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.560244

By:

Macarrón Palacios, Arturo;
Grzeschik, Julius;
Deweid, Lukas;
Krah, Simon;
Zielonka, Stefan;
Rösner, Thies;
Peipp, Matthias;
Valerius, Thomas;
Kolmar, Harald

Publication type:

Article

Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their Cytotoxicity.

Published in:

Frontiers in Immunology, 2020, p. 1, doi. 10.3389/fimmu.2020.01328

By:

Gonnermann, Daniel;
Oberg, Hans-Heinrich;
Lettau, Marcus;
Peipp, Matthias;
Bauerschlag, Dirk;
Sebens, Susanne;
Kabelitz, Dieter;
Wesch, Daniela

Publication type:

Article

TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02044

By:

Tawfik, Doaa;
Groth, Christopher;
Gundlach, Jan-Paul;
Peipp, Matthias;
Kabelitz, Dieter;
Becker, Thomas;
Oberg, Hans-Heinrich;
Trauzold, Anna;
Wesch, Daniela

Publication type:

Article

Inhibition of the JAK-STAT3-Mcl-1 Axis by Combining Ruxolitinib with S63845 Completely Prevents Plasmacytoma Growth in the Gp130-Regulated INA-6 Xenograft Mouse Model.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e129, doi. 10.1016/j.clml.2019.09.214

By:

Burger, Renate;
Otte, Anna;
Brdon, Jan-Wladyslaw;
Peipp, Matthias;
Gramatzki, Martin

Publication type:

Article

Potent Targeting of the Glycoantigen CD75s on Myeloma by the Tetravalent, Fc-Engineered Antibody 'EBU-141 Tetra'.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e17, doi. 10.1016/j.clml.2019.09.025

By:

Klausz, Katja;
Karimzadeh-Tabrizi, Amir;
Buck, Malena;
Krohn, Steffen;
Otte, Anna;
Roesner, Thies;
Valerius, Thomas;
Peipp, Matthias;
Gramatzki, Martin

Publication type:

Article

Impact of Human IgA Antibodies on Complement-Dependent Cytotoxicity Mediated by Combinations of EGF-R-Directed Antibodies.

Published in:

Archivum Immunologiae & Therapiae Experimentalis, 2010, v. 58, n. 4, p. 303, doi. 10.1007/s00005-010-0081-2

By:

Lohse, Stefan;
Peipp, Matthias;
Beyer, Thomas;
Valerius, Thomas;
Dechant, Michael

Publication type:

Article

Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions.

Published in:

Cancer Science, 2021, v. 112, n. 8, p. 3029, doi. 10.1111/cas.14999

By:

Baumann, Niklas;
Rösner, Thies;
Jansen, J. H. Marco;
Chan, Chilam;
Marie Eichholz, Klara;
Klausz, Katja;
Winterberg, Dorothee;
Müller, Kristina;
Humpe, Andreas;
Burger, Renate;
Peipp, Matthias;
Schewe, Denis M.;
Kellner, Christian;
Leusen, Jeanette H. W.;
Valerius, Thomas

Publication type:

Article

Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII).

Published in:

Cancer Science, 2011, v. 102, n. 10, p. 1761, doi. 10.1111/j.1349-7006.2011.02019.x

By:

Katja Klausz;
Berger, Sven;
Lammerts van Bueren, Jeroen J.;
Derer, Stefanie;
Lohse, Stefan;
Dechant, Michael;
van de Winkel, Jan G. J.;
Peipp, Matthias;
Parren, Paul W. H. I.;
Valerius, Thomas

Publication type:

Article

Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cells.

Published in:

Cancer Science, 2010, v. 101, n. 5, p. 1080, doi. 10.1111/j.1349-7006.2010.01505.x

By:

Schlaeth, Martin;
Berger, Sven;
Derer, Stefanie;
Klausz, Katja;
Lohse, Stefan;
Dechant, Michael;
Lazar, Greg A.;
Schneider-Merck, Tanja;
Peipp, Matthias;
Valerius, Thomas

Publication type:

Article

Optimised protocols for RNA extraction from a broad taxonomic range of algae.

Published in:

Journal of Applied Phycology, 2023, v. 35, n. 4, p. 1743, doi. 10.1007/s10811-023-02980-7

By:

Jensen, Timo;
Saleh, Livia;
Bents, Dominik;
Krohn, Steffen;
Wu, Yu-Chen;
Mucke, Maria;
Boje, Ammelie Svea;
Veltel, Stefan;
Hennig, Steffen;
Piker, Levent;
Peipp, Matthias;
Labes, Antje

Publication type:

Article

Isolation of polyphenols with anticancer activity from the Baltic Sea brown seaweed Fucus vesiculosus using bioassay-guided fractionation.

Published in:

Journal of Applied Phycology, 2017, v. 29, n. 4, p. 2021, doi. 10.1007/s10811-017-1080-z

By:

Zenthoefer, Marion;
Geisen, Ulf;
Hofmann-Peiker, Karsten;
Fuhrmann, Markus;
Kerber, Jannik;
Kirchhöfer, Renate;
Hennig, Steffen;
Peipp, Matthias;
Geyer, Roland;
Piker, Levent;
Kalthoff, Holger

Publication type:

Article

Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering.

Published in:

Antibodies (2073-4468), 2020, v. 9, n. 4, p. 63, doi. 10.3390/antib9040063

By:

Roßkopf, Sophia;
Eichholz, Klara Marie;
Winterberg, Dorothee;
Diemer, Katarina Julia;
Lutz, Sebastian;
Münnich, Ira Alexandra;
Klausz, Katja;
Rösner, Thies;
Valerius, Thomas;
Schewe, Denis Martin;
Humpe, Andreas;
Gramatzki, Martin;
Peipp, Matthias;
Kellner, Christian

Publication type:

Article

Monitoring circulating γδT cells in cancer patients to optimize γδT cell-based immunotherapy.

Published in:

Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00643

By:

Oberg, Hans-Heinrich;
Kellner, Christian;
Peipp, Matthias;
Sebens, Susanne;
Adam-Klages, Sabine;
Gramatzki, Martin;
Kabelitz, Dieter;
Wesch, Daniela;
Gustafsson, Kenth;
Massaia, Massimo

Publication type:

Article

γδ T cell-mediated antibody-dependent cellular cytotoxicity with CD19 antibodies assessed by an impedance-based label-free real-time cytotoxicity assay.

Published in:

Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00618

By:

Eva Seide, Ursula Jördis;
Vogt, Fabian;
Grosse-Hovest, Ludger;
Jung, Gundram;
Handgretinger, Rupert;
Lang, Peter;
Anderson, John;
Peipp, Matthias

Publication type:

Article

Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers.

Published in:

2024

By:

Boje, Ammelie Svea;
Pekar, Lukas;
Koep, Katharina;
Lipinski, Britta;
Rabinovich, Brian;
Evers, Andreas;
Gehlert, Carina Lynn;
Krohn, Steffen;
Xiao, Yanping;
Krah, Simon;
Zaynagetdinov, Rinat;
Toleikis, Lars;
Poetzsch, Sven;
Peipp, Matthias;
Zielonka, Stefan;
Klausz, Katja

Publication type:

Report

Generation and engineering of potent single domain antibody-based bispecific IL-18 mimetics resistant to IL-18BP decoy receptor inhibition.

Published in:

2023

By:

Lipinski, Britta;
Unmuth, Laura;
Arras, Paul;
Becker, Stefan;
Bauer, Christina;
Toleikis, Lars;
Krah, Simon;
Doerner, Achim;
Yanakieva, Desislava;
Boje, Ammelie Svea;
Klausz, Katja;
Peipp, Matthias;
Siegmund, Vanessa;
Evers, Andreas;
Kolmar, Harald;
Pekar, Lukas;
Zielonka, Stefan

Publication type:

Report

Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity.

Published in:

mAbs (1942-0862), 2014, v. 6, n. 2, p. 409, doi. 10.4161/mabs.27457

By:

Derer, Stefanie;
Glorius, Pia;
Schlaeth, Martin;
Lohse, Stefan;
Klausz, Katja;
Muchhal, Umesh;
Desjarlais, John R.;
Humpe, Andreas;
Valerius, Thomas;
Peipp, Matthias

Publication type:

Article

HER2 monoclonal antibodies that do not interfere with receptor heterodimerization-mediated signaling induce effective internalization and represent valuable components for rational antibody-drug conjugate design.

Published in:

mAbs (1942-0862), 2014, v. 6, n. 2, p. 392, doi. 10.4161/mabs.27705

By:

De Goeij, Bart E. C. G.;
Peipp, Matthias;
De Haij, Simone;
Van Den Brink, Edward N.;
Kellner, Christian;
Riedl, Thilo;
De Jong, Rob;
Vink, Tom;
Strumane, Kristin;
Bleeker, Wim K.;
Parren, Paul W. H. I.

Publication type:

Article

Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2 min(1) antibody.

Published in:

mAbs (1942-0862), 2013, v. 5, n. 6, p. 936, doi. 10.4161/mabs.26396

By:

Brunke, Christina;
Lohse, Stefan;
Derer, Stefanie;
Peipp, Matthias;
Boross, Peter;
Kellner, Christian;
Beyer, Thomas;
Dechant, Michael;
Royle, Louise;
Li Phing Liew;
Leusen, Jeanette H. W.;
Valerius, Thomas

Publication type:

Article

Antibody-Dependent Cellular Cytotoxicity in Patients on Chronic Hemodialysis.

Published in:

American Journal of Nephrology, 2013, v. 38, n. 5, p. 379, doi. 10.1159/000355972

By:

Koch, Till;
Derer, Stefanie;
Staudinger, Matthias;
Rossen, Kai;
Glorius, Pia;
Peipp, Matthias;
Kellner, Christian;
Kunzendorf, Ulrich;
Valerius, Thomas;
Dechant, Michael

Publication type:

Article

Molecular Mechanisms by Which a Fucus vesiculosus Extract Mediates Cell Cycle Inhibition and Cell Death in Pancreatic Cancer Cells.

Published in:

Marine Drugs, 2015, v. 13, n. 7, p. 4470, doi. 10.3390/md13074470

By:

Geisen, Ulf;
Zenthoefer, Marion;
Peipp, Matthias;
Kerber, Jannik;
Plenge, Johannes;
Managò, Antonella;
Fuhrmann, Markus;
Geyer, Roland;
Hennig, Steffen;
Adam, Dieter;
Piker, Levent;
Rimbach, Gerald;
Kalthoff, Holger

Publication type:

Article

Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1483617

By:

Nguyen, Oanh T. P.;
Lara, Sandra;
Ferro, Giovanni;
Peipp, Matthias;
Kleinau, Sandra

Publication type:

Article

Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity.

Published in:

2018

By:

Lohse, Stefan;
Loew, Sebastian;
Kretschmer, Anna;
Jansen, J. H. Marco;
Meyer, Saskia;
ten Broeke, Toine;
Rösner, Thies;
Dechant, Michael;
Derer, Stefanie;
Klausz, Katja;
Kellner, Christian;
Schwanbeck, Ralf;
French, Ruth R.;
Tipton, Thomas R. W.;
Cragg, Mark S.;
Schewe, Denis M.;
Peipp, Matthias;
Leusen, Jeanette H. W.;
Valerius, Thomas

Publication type:

Letter to the Editor

An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels.

Published in:

British Journal of Haematology, 2013, v. 161, n. 2, p. 282, doi. 10.1111/bjh.12209

By:

Rösner, Thies;
Derer, Stefanie;
Kellner, Christian;
Dechant, Michael;
Lohse, Stefan;
Vidarsson, Gestur;
Peipp, Matthias;
Valerius, Thomas

Publication type:

Article

The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03824-0

By:

Chan, Chilam;
Cabanes, Núria Casalé;
Jansen, J. H. Marco;
Guillaume, Joël;
Nederend, Maaike;
Passchier, Elsemieke M.;
Gómez-Mellado, Valentina E.;
Peipp, Matthias;
Boes, Marianne;
van Tetering, Geert;
Leusen, Jeanette H. W.

Publication type:

Article

Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 12, p. 2634, doi. 10.3390/jcm10122634

By:

Winterberg, Dorothee;
Lenk, Lennart;
Oßwald, Maren;
Vogiatzi, Fotini;
Gehlert, Carina Lynn;
Frielitz, Fabian-Simon;
Klausz, Katja;
Rösner, Thies;
Valerius, Thomas;
Trauzold, Anna;
Peipp, Matthias;
Kellner, Christian;
Schewe, Denis Martin

Publication type:

Article

Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1286097

By:

Schadeck, Jan;
Oberg, Hans-Heinrich;
Peipp, Matthias;
Hedemann, Nina;
Schamel, Wolfgang W.;
Bauerschlag, Dirk;
Wesch, Daniela

Publication type:

Article

Novel NKG2D-directed bispecific antibodies enhance antibodymediated killing of malignant B cells by NK cells and T cells.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1227572

By:

Lutz, Sebastian;
Klausz, Katja;
Albici, Anca-Maria;
Ebinger, Lea;
Sellmer, Lea;
Teipel, Hannah;
Frenzel, André;
Langner, Anna;
Winterberg, Dorothee;
Krohn, Steffen;
Hust, Michael;
Schirrmann, Thomas;
Dübel, Stefan;
Scherließ, Regina;
Humpe, Andreas;
Gramatzki, Martin;
Kellner, Christian;
Peipp, Matthias

Publication type:

Article

Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.

Published in:

Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1178817

By:

Lustig, Marta;
Chan, Chilam;
Jansen, J. H. Marco;
Bräutigam, Maria;
Kölling, Max A.;
Gehlert, Carina Lynn;
Baumann, Niklas;
Mester, Simone;
Foss, Stian;
Andersen, Jan Terje;
Bastian, Lorenz;
Sondermann, Peter;
Peipp, Matthias;
Burger, Renate;
Leusen, Jeanette H. W.;
Valerius, Thomas

Publication type:

Article

Combining Cellular Immunization and Phage Display Screening Results in Novel, FcγRI-Specific Antibodies.

Published in:

Viruses (1999-4915), 2024, v. 16, n. 4, p. 596, doi. 10.3390/v16040596

By:

Krohn, Steffen;
Holtrop, Tosca;
Brandsma, Arianne M.;
Moerer, Petra;
Nederend, Maaike;
Darzentas, Nikos;
Brüggemann, Monika;
Klausz, Katja;
Leusen, Jeanette H. W.;
Peipp, Matthias

Publication type:

Article

Enhanced ADCC Activity of Affinity Maturated and Fc-Engineered Mini- Antibodies Directed against the AML Stem Cell Antigen CD96.

Published in:

PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042426

By:

Nodehi, Sahar Mohseni;
Repp, Roland;
Kellner, Christian;
Bräutigam, Joachim;
Staudinger, Matthias;
Schub, Natalie;
Peipp, Matthias;
Gramatzki, Martin;
Humpe, Andreas;
Filion, Lionel G.

Publication type:

Article

Complement-Dependent Activity of CD20-Specific IgG Correlates With Bivalent Antigen Binding and C1q Binding Strength.

Published in:

Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.609941

By:

Bondza, Sina;
Marosan, Anita;
Kara, Sibel;
Lösing, Josephine;
Peipp, Matthias;
Nimmerjahn, Falk;
Buijs, Jos;
Lux, Anja

Publication type:

Article